“Can DPP-4 Enhibitors and SGLT-2 Inhibitors Pleotropic Effects be Extended to Treat Diabetic Nephropathy?” (2023) Journal of Medicine, 24(1), pp. 43–49. doi:10.3329/jom.v24i1.64903.